Chlorpromazine Syrup

Form: Oral Syrup

Strength: 30 mg/mL

Reference Brands: Largactil® (EU); Thorazine®(US)

Category: Antipsychotropic Drugs

Chlorpromazine syrup is FDA-approved in the United States for treating schizophrenia, severe behavioral disorders, nausea, and intractable hiccups. In the EU, it is available in select markets under national authorizations, primarily for pediatric and geriatric use. Regulatory requirements include GMP compliance, stability data for liquid dosage forms, and safety documentation addressing anticholinergic and sedative effects. U.S. submissions must follow FDA oral solution guidelines, including accurate dosing and child-resistant packaging. EU applications may require pharmacovigilance planning and pediatric-specific labeling. To explore dossier-ready Chlorpromazine syrup and alternative formulations, visit Pharmatradz.com — your global B2B pharma sourcing partner.